Molecular Mechanism of Curcumin Derivative on YAP Pathway against Ovarian Cancer

被引:3
作者
Zheng, Nan [1 ]
Liu, Shan [2 ]
Zeng, Huiting [1 ]
Zhao, Huajun [1 ]
Jin, Lixu [3 ]
机构
[1] Zhejiang Chinese Med Univ, Sch Pharm, Hangzhou 310053, Peoples R China
[2] Wenzhou Med Univ, Sch Pharm, Wenzhou 325015, Peoples R China
[3] Wenzhou Med Univ, Obstet Dept, Affiliated Hosp 1, Wenzhou 325015, Peoples R China
关键词
ovarian cancer; curcumin; WZ10; apoptosis; Hippo-YAP pathway;
D O I
10.3390/jcm11237220
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study is to study the effect of curcumin derivative WZ10 on the proliferation, invasion and apoptosis of ovarian cancer OVCAR3 cells, and to explore its mechanism. MTT assay was used to detect the effect of WZ10 on the proliferation of ovarian cancer OVCAR3 cells; Annexin V/PI double staining flow cytometry was used to detect the effect of WZ10 on cell apoptosis; Transwell method was used to detect the effect of WZ10 on cell invasiveness; Western blot was used to investigate the effect of WZ10 Mechanisms affecting OVCAR3 activity in ovarian cancer in vitro. Our results show that WZ10 treatment could significantly inhibit the proliferation and invasion of OVCAR3 cells, induce apoptosis of OVCAR3 cells in a dose-dependent manner. After knockdown of Hippo expression with sh-RNA, further combined treatment with WZ10 had no significant image on ovarian cancer OVCAR3 cells. In conclusion: WZ10 can significantly inhibit the proliferation of OVCAR3 cells, reduce cell invasion and proliferation by downregulating the activation of Hippo-YAP pathway, and induce cell apoptosis.
引用
收藏
页数:9
相关论文
共 22 条
[1]  
Bin W., 2019, CELL TRANSPLANT, V28, P1420
[2]   NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer [J].
Chang, Hua ;
Li, Baixue ;
Zhang, Xue ;
Meng, Xiangkai .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 522 (02) :292-299
[3]   11β-HSD1 Inhibitor Alleviates Non-Alcoholic Fatty Liver Disease by Activating the AMPK/SIRT1 Signaling Pathway [J].
Chen, Ying ;
Li, Jiali ;
Zhang, Meng ;
Yang, Wei ;
Qin, Wenqi ;
Zheng, Qinzhou ;
Chu, Yanhui ;
Wu, Yan ;
Wu, Dan ;
Yuan, Xiaohuan .
NUTRIENTS, 2022, 14 (11)
[4]   The Multiple Interactions of RUNX with the Hippo-YAP Pathway [J].
Chuang, Linda Shyue Huey ;
Ito, Yoshiaki .
CELLS, 2021, 10 (11)
[5]   OIP5-AS1/miR-137/ZNF217 Axis Promotes Malignant Behaviors in Epithelial Ovarian Cancer [J].
Guo, Linlin ;
Chen, Jiabao ;
Liu, Dong ;
Liu, Lili .
CANCER MANAGEMENT AND RESEARCH, 2020, 12 :6707-6717
[6]   Context-dependent transcriptional regulations of YAP/TAZ in cancer [J].
Guo, Yibo ;
Luo, Juan ;
Zou, Hailin ;
Liu, Chenxin ;
Deng, Liang ;
Li, Peng .
CANCER LETTERS, 2022, 527 :164-173
[7]   Human cytomegalovirus inhibits the proliferation and invasion of extravillous cytotrophoblasts via Hippo-YAP pathway [J].
Kong, Qiaoqiao ;
Li, Jing ;
Zhao, Li ;
Shi, Peng ;
Liu, Xiaobei ;
Bian, Cailing ;
Liu, Jing ;
Liu, Tao .
VIROLOGY JOURNAL, 2021, 18 (01)
[8]   SREBP1 promotes invasive phenotypes by upregulating CYR61/CTGF via the Hippo-YAP pathway [J].
Kuo, Chi-Yu ;
Chang, Yuan-Ching ;
Chien, Ming-Nan ;
Jhuang, Jie-Yang ;
Hsu, Yi-Chiung ;
Huang, Shih-Yuan ;
Cheng, Shih-Ping .
ENDOCRINE-RELATED CANCER, 2022, 29 (02) :47-58
[9]   Formulation of the novel structure curcumin derivative-loaded solid lipid nanoparticles: synthesis, optimization, characterization and anti-tumor activity screening in vitro [J].
Li, Ke ;
Pi, Chao ;
Wen, Jie ;
He, Yingmeng ;
Yuan, Jiyuan ;
Shen, Hongping ;
Zhao, Wenmei ;
Zeng, Mingtang ;
Song, Xinjie ;
Lee, Robert J. ;
Wei, Yumeng ;
Zhao, Ling .
DRUG DELIVERY, 2022, 29 (01) :2044-2057
[10]   MPDZ as a novel epigenetic silenced tumor suppressor inhibits growth and progression of lung cancer through the Hippo-YAP pathway [J].
Liu, Wenbin ;
Huang, Yongsheng ;
Wang, Dandan ;
Han, Fei ;
Chen, Hongqiang ;
Chen, Jianping ;
Jiang, Xiao ;
Cao, Jia ;
Liu, Jinyi .
ONCOGENE, 2021, 40 (26) :4468-4485